Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionGeneos Wealth Management Inc.
Latest Disclosed Ownership835 shares
Latest Disclosed Value $ 644,768
Geneos Wealth Management Inc. reports 1.83% increase in ownership of REGN / Regeneron Pharmaceuticals, Inc.

On May 4, 2026 - Geneos Wealth Management Inc. filed a 13F-HR form disclosing ownership of 835 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $644,768 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 820 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 1.83% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 835 15 1.83 645 1.90 0.0150
2026-01-28 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 820 -62 -7.03 633 27.68 0.0155
2025-10-22 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 882 102 13.08 496 21.03 0.0126
2025-08-18 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 780 23 3.04 410 -14.79 0.0100
2025-05-21 2025-03-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 757 67 9.71 480 -2.24 0.0161
2025-05-08 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 770 80 488 0.0123
2025-01-21 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 690 3 0.44 492 -31.99 0.0172
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 687 -119 -14.76 722 -14.76 0.0276
2024-07-23 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 806 -40 -4.73 847 4.05 0.0376
2024-05-03 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 846 -18 -2.08 814 7.39 0.0373
2024-01-26 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 864 -42 -4.64 759 1.74 0.0375
2023-10-11 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 906 -102 -10.12 746 2.90 0.0384
2023-08-08 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,008 -29 -2.80 724 -15.02 0.0379
2023-04-25 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,037 -49 -4.51 852 8.81 0.0517
2023-01-31 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,086 -37 -3.29 784 1.29 0.0475
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,123 8 0.72 773 16.59 0.0532
2022-07-22 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,115 -62 -5.27 663 -19.34 0.0328
2022-05-16 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,177 -30 -2.49 822 7.87 0.0353
2022-02-09 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,207 -23 -1.87 762 8.55 0.0290
2021-11-09 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,230 -191 -13.44 702 -15.32 0.0269
2021-07-08 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,421 -138 -8.85 829 10.53 0.0323
2021-06-17 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,559 -52 -3.23 750 -2.22 0.0209
2021-05-19 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,611 1,265 365.61 767 287.37 0.0308
2021-09-07 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 346 5 1.47 198 -4.81 0.0103
2021-09-07 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 341 -196 -36.50 208 -15.10 0.0116
2021-09-07 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 537 20 3.87 245 26.94 0.0165
2021-09-07 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 517 0 0.00 193 36.88 0.0103
2021-09-07 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 517 0 0.00 141 -12.42 0.0084
2021-09-07 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 517 0 0.00 161 -24.06 0.0100
2021-09-07 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 517 7 1.37 212 15.22 0.0140
2021-09-07 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 510 -40 -7.27 184 -17.12 0.0136
2021-09-07 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 550 0 0.00 222 17.46 0.0148
2021-09-07 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 550 -17 -3.00 189 -3.08 0.0147
2021-09-07 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 567 0 0.00 195 -8.45 0.0170
2021-09-07 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 567 0 0.00 213 -15.81 0.0190
2021-09-07 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 567 -1 -0.18 253 -8.99 0.0251
2021-09-07 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 568 -10 -1.73 278 24.66 0.0285
2021-09-07 2017-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 578 -11 -1.87 223 3.24 0.0232
2021-09-07 2016-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 589 0 0.00 216 -8.47 0.0285
2021-09-07 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 589 11 1.90 236 14.01 0.0318
2021-09-07 2016-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 578 0 0.00 207 -11.54 0.0300
2021-09-07 2016-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 578 578 234 0.0358
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.